molecules of the month


oral G2019S-LRRK2 mut.-selective kinase inh.

>70x sel. for ParkinsonÕs mut. over WT, non-BP

from 50k cmpd HTS + homology-based opt.

J. Med. Chem., Nov. 16, 2020

ESCAPE Bio, South San Francisco, CA

Structure of EB-42486 - a potent, oral inhibitor of leucine-rich repeat kinase 2 (LRRK2)
1 min read

EB-42486 (ESCAPE Bio oral G2019S-LRRK2 mutant-selective kinase inhibitor)

request a trial

You don’t have time to read everything, but you can’t afford to fall behind.

Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.

Get ahead now by requesting a trial.

already a member? log in: